Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
31.84
+1.01 (3.28%)
May 29, 2025, 4:00 PM - Market closed
Agios Pharmaceuticals Revenue
Agios Pharmaceuticals had revenue of $8.73M in the quarter ending March 31, 2025, with 6.56% growth. This brings the company's revenue in the last twelve months to $37.04M, up 25.96% year-over-year. In the year 2024, Agios Pharmaceuticals had annual revenue of $36.50M with 36.07% growth.
Revenue (ttm)
$37.04M
Revenue Growth
+25.96%
P/S Ratio
49.07
Revenue / Employee
$75,891
Employees
488
Market Cap
1.84B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
AGIO News
- 1 day ago - Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025 - GlobeNewsWire
- 15 days ago - Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress - GlobeNewsWire
- 20 days ago - Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025 - GlobeNewsWire
- 27 days ago - Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025 - GlobeNewsWire
- 4 weeks ago - Agios Pharmaceuticals, Inc. (AGIO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 6 weeks ago - Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025 - GlobeNewsWire
- 3 months ago - Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer - GlobeNewsWire